Publications by authors named "Shaun Sun"
Article Synopsis
- Canadian oncology patients often use patient assistance programs (PAPs) to access oncology drugs while waiting for funding, even within a universal healthcare system.
- A study reviewed the outcomes of 1,025 patients who received 40 oncology drugs, finding significant survival benefits with a median life-years gained calculated at 0.38 years for overall survival and 0.80 years for progression-free survival.
- The economic analysis revealed a total estimated value of quality-adjusted life years (QALY) gained of over $83 million, while the drug costs were about $97 million, highlighting the crucial role of PAPs in patient care and cost coverage.
2023 Canadian Surgery Forum: Sept. 20-23, 2023.
Can J Surg
January 2024
Background: Skin sparing mastectomy (SSM) with immediate breast reconstruction (IBR) has been established as a safe option for curative-intent surgical resection. Prior studies have shown that medial location of the primary tumor is associated with increased risk of local recurrence. The purpose of this study is to determine the factors associated with recurrence and survival in individuals with breast cancers located in the inner quadrants (medial) who underwent SSM with IBR.
View Article and Find Full Text PDFObjective: As vulvar and vaginal cancers are rare malignancies, treatment is extrapolated from the cervical cancer field. Further studies are necessary to evaluate whether surgery, radiotherapy (RT), or combined chemoRT is most beneficial.
Methods: A retrospective chart review was conducted on patients diagnosed with vulvar or vaginal cancer in 2000-2017.
Background: Factors that impact recurrence in stages IB to IV include larger tumor, high-risk histology, older age, and lymphovascular invasion (LVI); however, local studies on risk factors for recurrence in British Columbia and our local recurrence patterns have not been well studied. Furthermore, the efficacy of treatment modalities including surgery and chemoradiation in the different stages of cervical cancer have not been clarified in this population.
Objectives: The purpose of this study is to determine the disease and treatment characteristics of stages IB to IV cervical cancer which are associated with survival differences within British Columbia.
Background: Real-world data on palliative systemic therapies (PST) in treating metastatic bladder cancer (mBC) is limited. This study investigates current trends in treating mBC with first- (1L) and second-line (2L) chemotherapy (CT) and immunotherapy (IT).
Methods: A chart review was conducted on patients diagnosed with stage II-IV bladder cancer in 2014-2016.